Media headlines about National Research (NASDAQ:NRCIB) have trended somewhat negative recently, Accern reports. The research firm identifies positive and negative news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. National Research earned a daily sentiment score of -0.04 on Accern’s scale. Accern also assigned media stories about the business services provider an impact score of 43.6568126847622 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

NRCIB stock opened at $53.01 on Thursday. National Research has a 12 month low of $40.27 and a 12 month high of $58.16. The firm has a market capitalization of $1.30 billion, a P/E ratio of 91.40 and a beta of 0.39.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provide actionable information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience, satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement.

Insider Buying and Selling by Quarter for National Research (NASDAQ:NRCIB)

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with's FREE daily email newsletter.